With 1.09 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.89 million shares. The 52-week range on RNAZ shows that it touched its highest point at $66.33 and its lowest point at $1.30 during that stretch. It currently has a 1-year price target of $20.00. Beta for the stock currently stands at 1.24.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of RNAZ was down-trending over the past week, with a drop of -40.11%, but this was down by -88.64% over a month. Three-month performance dropped to -87.13% while six-month performance fell -87.15%. The stock lost -95.35% in the past year, while it has lost -66.77% so far this year. A look at the trailing 12-month EPS for RNAZ yields -265.83 with Next year EPS estimates of -144.21. For the next quarter, that number is -105.93. This implies an EPS growth rate of 95.41% for this year and 8.19% for next year. EPS is expected to grow by 78.85% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -28.81%.
Float and Shares Shorts:
At present, 0.70 million RNAZ shares are outstanding with a float of 0.66 million shares on hand for trading.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$157.08 being high and -$157.08 being low. For RNAZ, this leads to a yearly average estimate of -$157.08. Based on analyst estimates, the high estimate for the next quarter is -$1.48 and the low estimate is -$1.48. The average estimate for the next quarter is thus -$1.48.
